375 related articles for article (PubMed ID: 14871456)
1. Extracellular role of HMGB1 in inflammation and sepsis.
Wang H; Yang H; Tracey KJ
J Intern Med; 2004 Mar; 255(3):320-31. PubMed ID: 14871456
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the proinflammatory cytokine activity of high mobility group box 1.
Li J; Kokkola R; Tabibzadeh S; Yang R; Ochani M; Qiang X; Harris HE; Czura CJ; Wang H; Ulloa L; Wang H; Warren HS; Moldawer LL; Fink MP; Andersson U; Tracey KJ; Yang H
Mol Med; 2003; 9(1-2):37-45. PubMed ID: 12765338
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 as a potential therapeutic target.
Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 as a cytokine and therapeutic target.
Yang H; Wang H; Czura CJ; Tracey KJ
J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
[TBL] [Abstract][Full Text] [Related]
5. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
6. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department.
Sama AE; D'Amore J; Ward MF; Chen G; Wang H
Acad Emerg Med; 2004 Aug; 11(8):867-73. PubMed ID: 15289194
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 in sepsis.
Andersson U; Tracey KJ
Scand J Infect Dis; 2003; 35(9):577-84. PubMed ID: 14620138
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 as a DNA-binding cytokine.
Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative Effect of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) on HMGB1-Induced Septic Responses In Vitro and In Vivo.
Lee W; Kim KM; Bae JS
Am J Chin Med; 2015; 43(5):991-1012. PubMed ID: 26224030
[TBL] [Abstract][Full Text] [Related]
10. Role of HMGB1 in cardiovascular diseases.
Li W; Sama AE; Wang H
Curr Opin Pharmacol; 2006 Apr; 6(2):130-5. PubMed ID: 16487750
[TBL] [Abstract][Full Text] [Related]
11. Anti-septic effects of glyceollins in HMGB1-induced inflammatory responses in vitro and in vivo.
Lee W; Ku SK; Lee YM; Bae JS
Food Chem Toxicol; 2014 Jan; 63():1-8. PubMed ID: 24184598
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
Czura CJ; Yang H; Tracey KJ
J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
[TBL] [Abstract][Full Text] [Related]
13. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.
Sundén-Cullberg J; Norrby-Teglund A; Rouhiainen A; Rauvala H; Herman G; Tracey KJ; Lee ML; Andersson J; Tokics L; Treutiger CJ
Crit Care Med; 2005 Mar; 33(3):564-73. PubMed ID: 15753748
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Three Diketopiperazines from Marine-Derived Bacteria on HMGB1-Induced Septic Responses in Vitro and in Vivo.
Lee W; Ku SK; Park S; Kim KM; Choi H; Bae JS
Am J Chin Med; 2016; 44(6):1145-1166. PubMed ID: 27627916
[TBL] [Abstract][Full Text] [Related]
15. Delayed administration of D-Ala2-D-Leu5-enkephalin, a delta-opioid receptor agonist, improves survival in a rat model of sepsis.
Tang CW; Feng WM; Du HM; Bao Y; Zhu M
Tohoku J Exp Med; 2011 May; 224(1):69-76. PubMed ID: 21551984
[TBL] [Abstract][Full Text] [Related]
16. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
Lutz W; Stetkiewicz J
Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.
Stevens NE; Chapman MJ; Fraser CK; Kuchel TR; Hayball JD; Diener KR
Sci Rep; 2017 Jul; 7(1):5850. PubMed ID: 28724977
[TBL] [Abstract][Full Text] [Related]
18. Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo.
Tsoyi K; Lee TY; Lee YS; Kim HJ; Seo HG; Lee JH; Chang KC
Mol Pharmacol; 2009 Jul; 76(1):173-82. PubMed ID: 19366789
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo.
Yang EJ; Lee W; Song KS; Bae JS
Biochem Pharmacol; 2016 Jun; 110-111():58-70. PubMed ID: 27106082
[TBL] [Abstract][Full Text] [Related]
20. The cytokine activity of HMGB1.
Yang H; Wang H; Czura CJ; Tracey KJ
J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]